• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS PROGESTERONE; RADIOIMMUNOASSAY, PROGESTERONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS PROGESTERONE; RADIOIMMUNOASSAY, PROGESTERONE Back to Search Results
Catalog Number 33550
Device Problem High Test Results (2457)
Patient Problem No Code Available (3191)
Event Date 05/20/2019
Event Type  Injury  
Manufacturer Narrative
Customer did not provide patient demographics such as age, date of birth, weight, ethnicity or race.No hardware errors or other assay issues were reported in conjunction with this event by the customer.The instrument is correctly maintained by the customer.No issues with sample integrity were reported by the customer.Calibration passed on 20may2019.Qc was passing within the laboratory¿s established ranges at the time of the event.Per the progesterone instructions for use, part number: a34447 m, the range of observations for non-pregnant females in the mid-follicular phase is 0.31-1.52 ng/ml.The progesterone reagent was not returned for evaluation.The cause of this incident cannot be determined with the available information.The beckman coulter internal identifier for this event is case-(b)(4).
 
Event Description
The customer reported obtaining erroneously elevated progesterone patient results on their unicel dxi 800 access immunoassay system (s/n: (b)(4)).The customers patient results were higher than the normal range of the assay.Results were also discordant with the roche method.No further information was provided on the roche method.There was a change in patient treatment.Some patients (number unknown) were treated based upon the elevated access progesterone results.Gnrh antagonist was given to those patients under ivf procedure to lower their progesterone level.The duration of the treatment varied between 10-15 days and the embryo transfer may be one month delayed.There was no further report of change to treatment nor any other adverse effect reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS PROGESTERONE
Type of Device
RADIOIMMUNOASSAY, PROGESTERONE
Manufacturer (Section D)
BECKMAN COULTER
250 s kraemer blvd
brea CA 92821 8000
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
david davis
1000 lake hazeltine drive
chaska, MN 55318
7149613796
MDR Report Key8674230
MDR Text Key147176556
Report Number2122870-2019-01082
Device Sequence Number1
Product Code JLS
UDI-Device Identifier15099590231378
UDI-Public(01)15099590231378(17)200430(11)20200430(10)832149
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K955769
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 06/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2020
Device Catalogue Number33550
Device Lot Number832149
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/20/2019
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/08/2016
Is the Device Single Use? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-